Drug intelligence / Profile preview

Chang'e Jiali Wan

Development stage: Unknown
Lead developer: Taiji Group Chongqing Tongjunge Pharmaceutical
Administration: Oral

Overview

Chang'e Jiali Wan is a Traditional Chinese Medicine (TCM) proprietary formulation primarily used in the field of gynecology and reproductive medicine. It is composed of multiple herbal ingredients, typically including *Cistanche deserticola*, *Epimedium*, *Angelica sinensis*, and *Rehmannia glutinosa*, which are traditionally used to 'tonify the kidney' and 'nourish the blood.' In clinical practice, it is employed to treat conditions such as ovarian endometriosis (specifically ovarian chocolate cysts), premature ovarian failure, and female infertility. The drug is thought to work by regulating the hypothalamic-pituitary-ovarian axis, improving ovarian reserve, and modulating the pelvic inflammatory environment to enhance fertility outcomes. It is currently being evaluated in randomized clinical trials, such as those led by the Obstetrics and Gynecology Hospital Affiliated to Fudan University, to assess its efficacy in improving biochemical and clinical pregnancy rates in women with ovarian endometriosis.

Brand names: Chang'e Jiali Wan
Other names: 嫦娥加丽丸Chang'e Jiali Pills

Beyond the preview

Go deeper on Chang'e Jiali Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chang'e Jiali Wan.

Explore the full profile